249 related articles for article (PubMed ID: 23454117)
1. Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity.
Feraco A; Armani A; Mammi C; Fabbri A; Rosano GM; Caprio M
J Steroid Biochem Mol Biol; 2013 Sep; 137():99-106. PubMed ID: 23454117
[TBL] [Abstract][Full Text] [Related]
2. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism.
Marzolla V; Armani A; Zennaro MC; Cinti F; Mammi C; Fabbri A; Rosano GM; Caprio M
Mol Cell Endocrinol; 2012 Mar; 350(2):281-8. PubMed ID: 21945603
[TBL] [Abstract][Full Text] [Related]
3. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
Jing F; Mogi M; Horiuchi M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):23-8. PubMed ID: 22465098
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor activation in obesity hypertension.
Nagase M; Fujita T
Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
[TBL] [Abstract][Full Text] [Related]
5. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.
Caprio M; Fève B; Claës A; Viengchareun S; Lombès M; Zennaro MC
FASEB J; 2007 Jul; 21(9):2185-94. PubMed ID: 17384139
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid-stimulating activity of adipose tissue.
Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217
[TBL] [Abstract][Full Text] [Related]
7. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.
Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I
Cardiovasc Res; 2009 Oct; 84(1):164-72. PubMed ID: 19505930
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone Production and Signaling Dysregulation in Obesity.
Vecchiola A; Lagos CF; Carvajal CA; Baudrand R; Fardella CE
Curr Hypertens Rep; 2016 Mar; 18(3):20. PubMed ID: 26838033
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptors in the metabolic syndrome.
Zennaro MC; Caprio M; Fève B
Trends Endocrinol Metab; 2009 Nov; 20(9):444-51. PubMed ID: 19800255
[TBL] [Abstract][Full Text] [Related]
10. The mineralocorticoid receptor: a new player controlling energy homeostasis.
Kuhn E; Lombès M
Horm Mol Biol Clin Investig; 2013 Sep; 15(2):59-69. PubMed ID: 25436733
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
Kawarazaki W; Fujita T
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone in vascular and metabolic dysfunction.
Luther JM
Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
[TBL] [Abstract][Full Text] [Related]
14. Modulation of glucose metabolism by the renin-angiotensin-aldosterone system.
Favre GA; Esnault VL; Van Obberghen E
Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E435-49. PubMed ID: 25564475
[TBL] [Abstract][Full Text] [Related]
15. Vascular actions of aldosterone.
Briet M; Schiffrin EL
J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
[TBL] [Abstract][Full Text] [Related]
16. The renin angiotensin aldosterone system and insulin resistance in humans.
Underwood PC; Adler GK
Curr Hypertens Rep; 2013 Feb; 15(1):59-70. PubMed ID: 23242734
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.
Urbanet R; Nguyen Dinh Cat A; Feraco A; Venteclef N; El Mogrhabi S; Sierra-Ramos C; Alvarez de la Rosa D; Adler GK; Quilliot D; Rossignol P; Fallo F; Touyz RM; Jaisser F
Hypertension; 2015 Jul; 66(1):149-57. PubMed ID: 25966493
[TBL] [Abstract][Full Text] [Related]
18. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
[TBL] [Abstract][Full Text] [Related]
19. [Renin-aldosterone and bone metabolism].
Ikeda K
Clin Calcium; 2014 Jun; 24(6):885-91. PubMed ID: 24870840
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
Bender SB; McGraw AP; Jaffe IZ; Sowers JR
Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
